STOCK TITAN
  1. Home
  2. Sec-filings
  3. STTK
  4. [SCHEDULE 13G/A] Shattuck Labs, Inc. SEC Filing

[SCHEDULE 13G/A] Shattuck Labs, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock STTK logo
Shattuck Labs, Inc.

NASDAQ:STTK

STTK Rankings

#5299 Ranked by Market Cap
N/A Ranked by Dividends

STTK Latest News

Aug 26, 2025
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
Aug 21, 2025
Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease
Aug 14, 2025
Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Aug 5, 2025
Shattuck Labs Announces Oversubscribed Private Placement of Up to Approximately $103 Million
Jul 2, 2025
Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism

STTK Latest SEC Filings

Aug 27, 2025
[Form 4] Shattuck Labs, Inc. Insider Trading Activity
Aug 27, 2025
[Form 4] Shattuck Labs, Inc. Insider Trading Activity
Aug 27, 2025
[Form 4] Shattuck Labs, Inc. Insider Trading Activity
Aug 27, 2025
[Form 4] Shattuck Labs, Inc. Insider Trading Activity
Aug 27, 2025
[Form 4] Shattuck Labs, Inc. Insider Trading Activity

STTK Stock Data

47.90M
40.95M
14.36%
59.03%
0.9%
Biotechnology
Pharmaceutical Preparations
Link
United States
AUSTIN